Cargando…
Sequencing of Androgen-Deprivation Therapy of Short Duration With Radiotherapy for Nonmetastatic Prostate Cancer (SANDSTORM): A Pooled Analysis of 12 Randomized Trials
The sequencing of androgen-deprivation therapy (ADT) with radiotherapy (RT) may affect outcomes for prostate cancer in an RT-field size-dependent manner. Herein, we investigate the impact of ADT sequencing for men receiving ADT with prostate-only RT (PORT) or whole-pelvis RT (WPRT). MATERIALS AND ME...
Autores principales: | Ma, Ting Martin, Sun, Yilun, Malone, Shawn, Roach, Mack, Dearnaley, David, Pisansky, Thomas M., Feng, Felix Y., Sandler, Howard M., Efstathiou, Jason A., Syndikus, Isabel, Hall, Emma C., Tree, Alison C., Sydes, Matthew R., Cruickshank, Claire, Roy, Soumyajit, Bolla, Michel, Maingon, Philippe, De Reijke, Theo, Nabid, Abdenour, Carrier, Nathalie, Souhami, Luis, Zapatero, Almudena, Guerrero, Araceli, Alvarez, Ana, Gonzalez San-Segundo, Carmen, Maldonado, Xavier, Romero, Tahmineh, Steinberg, Michael L., Valle, Luca F., Rettig, Matthew B., Nickols, Nicholas G., Shoag, Jonathan E., Reiter, Robert E., Zaorsky, Nicholas G., Jia, Angela Y., Garcia, Jorge A., Spratt, Daniel E., Kishan, Amar U. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902004/ https://www.ncbi.nlm.nih.gov/pubmed/36269935 http://dx.doi.org/10.1200/JCO.22.00970 |
Ejemplares similares
-
Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate
por: Roy, Soumyajit, et al.
Publicado: (2023) -
Global Ramifications of Dust and Sandstorm Microbiota
por: Behzad, Hayedeh, et al.
Publicado: (2018) -
Why super sandstorm 2021 in North China?
por: Yin, Zhicong, et al.
Publicado: (2021) -
Up in the Air: The Emerging Science of Dust and Sandstorm Microbes
por: McGrath, Casey
Publicado: (2018) -
Radiation therapy dose and androgen deprivation therapy in localized prostate cancer: a meta-regression of 5-year outcomes in phase III randomized controlled trials
por: Jiang, Tommy, et al.
Publicado: (2021)